Financials Clínica Baviera, S.A.

Equities

CBAV

ES0119037010

Healthcare Facilities & Services

Market Closed - BME 11:35:26 2024-04-26 am EDT 5-day change 1st Jan Change
28.1 EUR -1.06% Intraday chart for Clínica Baviera, S.A. -1.06% +22.17%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 221 233.1 229.9 345.6 284.5 375
Enterprise Value (EV) 1 224.4 280.1 257.6 364.7 293.8 372.5
P/E ratio 18.7 x 18.2 x 16.5 x 12.6 x 9.64 x 10.4 x
Yield 4.28% - 3.91% 4.86% 7.45% 6.83%
Capitalization / Revenue 2.02 x 1.87 x 1.87 x 1.99 x 1.43 x 1.65 x
EV / Revenue 2.05 x 2.25 x 2.1 x 2.11 x 1.48 x 1.64 x
EV / EBITDA 10.3 x 8.94 x 7.76 x 6.84 x 5.18 x 5.6 x
EV / FCF 35.9 x 17.1 x 12 x 11.5 x 8.82 x 13.9 x
FCF Yield 2.79% 5.85% 8.35% 8.68% 11.3% 7.2%
Price to Book 7.75 x 7.62 x 5.17 x 6.33 x 4.22 x 4.12 x
Nbr of stocks (in thousands) 16,306 16,302 16,303 16,302 16,303 16,303
Reference price 2 13.55 14.30 14.10 21.20 17.45 23.00
Announcement Date 4/26/19 6/16/20 4/13/21 4/12/22 4/8/24 4/8/24
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 109.3 124.3 122.6 173.2 198.4 227.1
EBITDA 1 21.69 31.34 33.21 53.35 56.76 66.5
EBIT 1 16.98 18.32 19.83 39.46 41.96 50.04
Operating Margin 15.54% 14.73% 16.17% 22.78% 21.14% 22.04%
Earnings before Tax (EBT) 1 16.81 17.79 20.19 38.9 40.68 49.65
Net income 1 11.83 12.79 13.94 27.39 29.52 35.97
Net margin 10.82% 10.29% 11.37% 15.81% 14.87% 15.84%
EPS 2 0.7254 0.7848 0.8553 1.680 1.811 2.206
Free Cash Flow 1 6.253 16.38 21.5 31.68 33.33 26.81
FCF margin 5.72% 13.17% 17.54% 18.28% 16.79% 11.81%
FCF Conversion (EBITDA) 28.83% 52.26% 64.75% 59.37% 58.72% 40.31%
FCF Conversion (Net income) 52.88% 127.99% 154.24% 115.65% 112.9% 74.52%
Dividend per Share 2 0.5800 - 0.5520 1.030 1.300 1.570
Announcement Date 4/26/19 6/16/20 4/13/21 4/12/22 4/8/24 4/8/24
1EUR in Million2EUR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2022 Q1 2022 Q2 2022 S1 2022 Q3 2022 Q4
Net sales 1 52.39 50.25 102.6 42.07 53.74
EBITDA 1 18.61 15.35 33.96 10.3 12.23
EBIT 1 15.03 11.59 26.62 6.5 8.375
Operating Margin 28.69% 23.06% 25.93% 15.45% 15.58%
Earnings before Tax (EBT) 1 14.92 11.49 26.42 6.365 7.899
Net income 1 11.11 8.455 19.56 4.606 5.351
Net margin 21.2% 16.83% 19.06% 10.95% 9.96%
EPS - - - - -
Dividend per Share - - - - -
Announcement Date 5/17/22 7/26/22 7/26/22 11/16/22 2/28/23
1EUR in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 3.42 47 27.8 19.1 9.31 -
Net Cash position 1 - - - - - 2.49
Leverage (Debt/EBITDA) 0.1576 x 1.499 x 0.8358 x 0.3586 x 0.164 x -
Free Cash Flow 1 6.25 16.4 21.5 31.7 33.3 26.8
ROE (net income / shareholders' equity) 44.4% 43.3% 37.3% 55.7% 48.7% 45.7%
ROA (Net income/ Total Assets) 19.3% 14.5% 11.1% 19.4% 18.5% 19%
Assets 1 61.18 87.95 125.1 141.4 159.8 189.1
Book Value Per Share 2 1.750 1.880 2.730 3.350 4.130 5.580
Cash Flow per Share 2 0.2400 0.2400 0.6600 0.6000 1.180 0.5100
Capex 1 9.18 9.19 7.82 10.6 14 22.7
Capex / Sales 8.4% 7.39% 6.38% 6.1% 7.07% 9.99%
Announcement Date 4/26/19 6/16/20 4/13/21 4/12/22 4/8/24 4/8/24
1EUR in Million2EUR
Estimates
  1. Stock Market
  2. Equities
  3. CBAV Stock
  4. Financials Clínica Baviera, S.A.